Does ABATACEPT Cause Central venous catheterisation? 8 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Central venous catheterisation have been filed in association with ABATACEPT (ORENCIA). This represents 0.0% of all adverse event reports for ABATACEPT.
8
Reports of Central venous catheterisation with ABATACEPT
0.0%
of all ABATACEPT reports
2
Deaths
6
Hospitalizations
How Dangerous Is Central venous catheterisation From ABATACEPT?
Of the 8 reports, 2 (25.0%) resulted in death, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABATACEPT. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ABATACEPT Cause?
Drug ineffective (35,212)
Rheumatoid arthritis (21,898)
Pain (19,783)
Arthralgia (18,536)
Joint swelling (18,453)
Contraindicated product administered (13,559)
Fatigue (13,087)
Drug intolerance (12,451)
Rash (12,168)
Arthropathy (11,099)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
Which ABATACEPT Alternatives Have Lower Central venous catheterisation Risk?
ABATACEPT vs ABATACEPT SUBQ /ML
ABATACEPT vs ABCIXIMAB
ABATACEPT vs ABEMACICLIB
ABATACEPT vs ABILIFY
ABATACEPT vs ABIRATERONE